Lineage Cell Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · Carlsbad, CA, United States
- PrincipalsBrian M CulleyPresident and CEOJill Ann HoweChief Financial Officerand 1 more
- CompanyLineage Cell Therapeutics, Inc.Carlsbad, CA, United States
- Phone line+1 (510) 521-3390General business
Lineage Cell Therapeutics, Inc. is an SEC-registered NYSE-listed company (ticker LCTX) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Chief executive
Brian M CulleyPresident and CEO
Finance
Jill Ann HoweChief Financial Officer
Legal
George A. Samuel IIIGeneral Counsel and Secretary
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Jill Ann Howe — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Brian M Culley — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗George A. Samuel III — General Counsel and Secretary
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
enGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityLeef Brands Inc.Medicinal Chemicals & Botanical Products · Vancouver1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capability